ARTICLE | Editor’s Commentary
What are biotechs, pharmas and academics getting wrong about each other?
By C. Simone Fishburn, Editor in Chief
November 6, 2024 8:35 PM UTC
Our industry is rife with myths that shape its sectors’ perceptions of each other. The cost is that it slows down, impairs, or even prevents the transfer of ideas and assets that’s fundamental to the journey of a therapy from lab to patient.
It takes a delicate constellation of players to pass the ball along in this journey, and as the biopharma ecosystem evolves, its members aren’t always fast to realize the changes happening around them. This means that despite a lot of progress, there’s still wasted energy and lost opportunities because of these myths, misperceptions and misreadings of incentives…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/654025/myths-and-misperceptions-industry-s-stumbling-blocks